High costs for doctor’s visits, medications and supplies force many diabetes patients to forgo or delay routine care. Patients and lawmakers have expressed outrage at the rising price of insulin, which Type 1 diabetes patients must take their entire lives and is sometimes required to keep Type 2 patients’ disease under control. Last month, the National Clinical Care Commission endorsed limiting insulin price increases to the rate of inflation.

Experts in the care and costs of diabetes will debate the need for a more comprehensive approach to this deadly disease and outline some of the ways the U.S. health care system can make care for patients with diabetes more affordable.